405 related articles for article (PubMed ID: 26610659)
1. FDG PET/CT Imaging of Carotid Atherosclerosis.
Ali A; Tawakol A
Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659
[TBL] [Abstract][Full Text] [Related]
2. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
3. ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.
Segtnan EA; Hess S; Grupe P; Høilund-Carlsen PF
PET Clin; 2015 Jan; 10(1):59-73. PubMed ID: 25455880
[TBL] [Abstract][Full Text] [Related]
4. Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study.
Blomberg BA; Thomassen A; Takx RA; Hildebrandt MG; Simonsen JA; Buch-Olsen KM; Diederichsen AC; Mickley H; Alavi A; Høilund-Carlsen PF
J Nucl Cardiol; 2014 Jun; 21(3):588-97. PubMed ID: 24633502
[TBL] [Abstract][Full Text] [Related]
5. A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT.
Hjelmgren O; Johansson L; Prahl U; Schmidt C; Fredén-Lindqvist J; Bergström GML
Eur J Radiol; 2014 Jul; 83(7):1184-1189. PubMed ID: 24767629
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis.
De Geeter F; Gykiere P
Hell J Nucl Med; 2016; 19(1):5-6. PubMed ID: 26929934
[TBL] [Abstract][Full Text] [Related]
7. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG-PET/CT in fever of unknown origin: clinical value.
Buch-Olsen KM; Andersen RV; Hess S; Braad PE; Schifter S
Nucl Med Commun; 2014 Sep; 35(9):955-60. PubMed ID: 24801131
[TBL] [Abstract][Full Text] [Related]
9. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.
Marnane M; Merwick A; Sheehan OC; Hannon N; Foran P; Grant T; Dolan E; Moroney J; Murphy S; O'Rourke K; O'Malley K; O'Donohoe M; McDonnell C; Noone I; Barry M; Crowe M; Kavanagh E; O'Connell M; Kelly PJ
Ann Neurol; 2012 May; 71(5):709-18. PubMed ID: 22461139
[TBL] [Abstract][Full Text] [Related]
10. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
[TBL] [Abstract][Full Text] [Related]
11. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
12. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
[TBL] [Abstract][Full Text] [Related]
13. Utility of Combining PET and MR Imaging of Carotid Plaque.
Vesey AT; Dweck MR; Fayad ZA
Neuroimaging Clin N Am; 2016 Feb; 26(1):55-68. PubMed ID: 26610660
[TBL] [Abstract][Full Text] [Related]
14. When to image carotid plaque inflammation with FDG PET/CT.
Graebe M; Borgwardt L; Højgaard L; Sillesen H; Kjaer A
Nucl Med Commun; 2010 Sep; 31(9):773-9. PubMed ID: 20543757
[TBL] [Abstract][Full Text] [Related]
15. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
[TBL] [Abstract][Full Text] [Related]
16. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
Wassélius J; Larsson S; Jacobsson H
Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839
[TBL] [Abstract][Full Text] [Related]
17. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
19. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
20. 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals.
Müller HF; Viaccoz A; Fisch L; Bonvin C; Lovblad KO; Ratib O; Lalive P; Pagano S; Vuilleumier N; Willi JP; Sztajzel R
Stroke; 2014 Dec; 45(12):3561-6. PubMed ID: 25370581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
